Distinct proteolytic mechanisms in serum-sufficient and serum-restricted fibroblasts. Transformed 3T3 cells fail to regulate proteolysis in relation to culture density only during serum-sufficiency.
Thymidine incorporation (reflecting cell division), degradation of long-half-life proteins and protein synthesis were compared in normal Swiss mouse 3T3 fibroblasts and their counterparts transformed by simian virus 40 at both high and low culture densities (no. of cells/cm2). Normal cells maintained faster proteolysis at high culture density than at low. Degradation was in all conditions enhanced by serum deprivation (1% serum). In serum-sufficient (10%) conditions, there was an inverse correlation between degradation and cell division, but in serum-restricted conditions proteolysis increased substantially as culture density was increased, without change in cell division. Protein synthesis generally changed in a converse sense to protein degradation. In serum-sufficient conditions, transformed 3T3 cells failed to regulate proteolysis in response to culture density. However, in serum-restricted conditions they can regulate proteolysis as do normal cells. Transformed 3T3 cells regulate protein synthesis and thymidine incorporation very poorly in response to culture density in both conditions studied. The failure of regulation of both protein synthesis and degradation may contribute to the exaggerated growth of transformed cells in serum-sufficient conditions. The retention by such cells of regulation of proteolysis during serum restriction may also aid their survival. Studies with several lysosomotropic agents indicated that lysosomes contribute to proteolysis in all conditions studied, but also that its regulation in serum restriction is distinct from that in serum sufficiency, and may involve primarily a non-lysosomal mechanism.
D000818:Animals; D001769:Blood; D002452:Cell Count; D002460:Cell Line; D002472:Cell Transformation, Viral; D004247:DNA / Q000096:biosynthesis; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism*; D006133:Growth Substances / Q000494:pharmacology*; D008247:Lysosomes / Q000378:metabolism; D051379:Mice; D008815:Mice, Inbred Strains; D011480:Protease Inhibitors / Q000494:pharmacology; D011506:Proteins / Q000378:metabolism*
D006133:Growth Substances; D011480:Protease Inhibitors; D011506:Proteins; D004247:DNA